Corpus Intelligence IC Memo — MERCY HOSPITAL OF DEFIANCE LLC 2026-04-26 14:15 UTC
IC Memo — MERCY HOSPITAL OF DEFIANCE LLC
Investment Committee Memorandum | OH | 23 beds | Grade C | EBITDA uplift $3.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HOSPITAL OF DEFIANCE LLC

CCN 360270 | DEFIANCE, OH | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERCY HOSPITAL OF DEFIANCE LLC is a 23-bed rural/critical access in DEFIANCE, OH with $50.4M in net patient revenue and a -15.3% operating margin. The hospital serves a payer mix of 44.0% Medicare, 1.5% Medicaid, and 54.5% commercial.

Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.3% to -8.0% (+736bps).

Net Revenue HCRIS$50.4M
Current EBITDA COMPUTED$-7.7M
Operating Margin COMPUTED-15.3%
Occupancy HCRIS37.1%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS28.1%
Distress Probability ML49.3%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
76
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -15.3% places it below the state median. Among 76 size-comparable peers (12-46 beds), the median margin is -1.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 76 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HOSPITAL OF DEFIANCE LL (Target)OH23$50.4M-15.3%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%
UH SAMARITAN MEDICAL CENTEROH39$88.9M-3.5%
MERCER COUNTY COMMUNITY HOSPITOH42$87.8M-0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.1M+210bp18mo
Cost to Collect4.5%2.5%$1.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$997K+198bp12mo
A/R Days Reduction5200.0%3800.0%$613K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.1M
Cost to Collect
$1.0M
Denial Rate Reduction
$997K
A/R Days Reduction
$613K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.7M
Current EBITDA$-7.7M
+ RCM Uplift+$3.7M
Pro Forma EBITDA$-4.0M
Current Margin-15.3%
Pro Forma Margin-8.0%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-11.9M$-13.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-11.9M$-19.1M0.00x-100.0%
Bull Case9.0x11.0x$-10.7M$-10.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.7M$-14.9M0.00x-100.0%
Bear Case11.0x10.0x$-13.1M$-28.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.1M$-35.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 76 hospitals with 12-46 beds
  • Same-state prioritization (n=77)
  • Comp margins: P25=-11.4% / P50=-1.9% / P75=11.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.